On March 23, 2007, the Centers for Medicare & Medicaid Services (CMS) published a Notice in the Federal Register announcing a CMS Ruling that establishes a process for own motion review of Medicare Part D prescription drug cases by the Medicare Appeals Council (MAC).
According to the Notice, the CMS Ruling permits CMS or a Medicare Part D independent review entity (IRE) to refer a Medicare Part D case to the MAC, and for the MAC to accept review, if an administrative law judge's (ALJ) decision or dismissal:
- contains an error of law material to the outcome of the case; or
- presents a broad policy or procedural issue that may affect the general public interest.
However, the CMS Ruling does not allow a Medicare Part D
plan sponsor to refer a Medicare Part D case to the MAC for own motion review. Nevertheless, the Notice states that Medicare Part D plan sponsors will "continue to have the
opportunity to communicate with the Part D IRE about cases that may
warrant such referral."
Further, the CMS Ruling applies many of the provisions in 42 C.F.R. 405.1110 to Medicare Part D cases. For instance, the CMS Ruling indicates that a 60-day time frame for filing a written referral, and for providing notice to other interested parties, is appropriate for Part D cases. In the Notice, CMS also cites other existing appeal provisions that would be applicable to the Part D cases.
According to the Notice, the CMS Ruling became effective on March 15, 2007, and after being signed by Acting CMS Administrator, Leslie V. Norwalk.